You are here
PREVAIL trial: post-hoc analysis update
The experts discussed the results of the post-hoc analysis of the PREVAIL study which showed that there is a subset of men in whom there is radiological progression even when the prostate specific antigen (PSA) limits are in the range. They further discussed the importance of reimaging in such scenarios and the schedule of reimaging that should be followed. They emphasized on the need for standard guidelines for imaging in the management of prostate cancer.